[Levetiracetam: a molecule with a novel mechanism of action in the pharmaceutical treatment of epilepsy].
Semmelweis Egyetem, Gyógyszerhatástani Intézet, Budapest. szokeva@net.sote.hu
Eva
E
Szökó
D000200:Action Potentials / Q000187:drug effects; D000927:Anticonvulsants / Q000378:metabolism / Q000494:pharmacology*; D015220:Calcium Channels / Q000187:drug effects; D004828:Epilepsies, Partial / Q000188:drug therapy* / Q000378:metabolism*; D006801:Humans; D000077287:Levetiracetam; D010889:Piracetam / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology*; D015221:Potassium Channels / Q000187:drug effects; D011487:Protein Conformation / Q000187:drug effects; D011963:Receptors, GABA-A / Q000187:drug effects* / Q000378:metabolism*
D000927:Anticonvulsants; D015220:Calcium Channels; D015221:Potassium Channels; D011963:Receptors, GABA-A; D000077287:Levetiracetam; D010889:Piracetam